Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Estrogen antagonists as treatments for sclerosing disorders

Estrogen antagonists as treatments for sclerosing disorders

US Patent 8969326 · Granted Mar 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Endostatin fragments and variants for use in treating fibrosis2024
Materials and methods for producing endostatin fusion polypeptides in plant cell2020
Use of endostatin peptides for the treatment of fibrosis2020
Use of endostatin peptides for the treatment of fibrosis2019
Antifibrotic effects of oxetanyl sulfoxides2018
Antifibrotic effects of oxetanyl sulfoxides2017
Estrogen antagonists as treatments for sclerosing disorders2017
Estrogen antagonists as treatments for sclerosing disorders2017
Use of endostatin peptides for the treatment of fibrosis2017
Use of endostatin peptides for the treatment of fibrosis2016
Use of endostatin peptides for the treatment of fibrosis2014
Use of endostatin peptides for the treatment of fibrosis2013